MiniMed Group (MMED) Reiterated at Buy by StoneX Ahead of Q1 Earnings
StoneX analyst Bruce Jackson reiterated a Buy rating and $20.00 price target on MiniMed Group (NASDAQ: MMED).The analyst commented, "MiniMed ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)